Cullinan Therapeutics Inc
(CGEM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 63,250 | N/A | N/A |
| Marketable Securities | 35,380 | N/A | N/A |
| TOTAL | $100,091 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 182 | N/A | N/A |
| Other Non-Current Assets | 188 | 0 | 0 |
| TOTAL | $370 | $N/A | $N/A |
| Total Assets | $100,461 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 934 | 0 | 0 |
| Accrued Expenses | 1,589 | N/A | N/A |
| TOTAL | $2,523 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 138,844 | 0 | 0 |
| TOTAL | $137,847 | $N/A | $N/A |
| Total Liabilities | $140,370 | $N/A | $N/A |
| Shareholders' Equity | |||
| Retained earnings | -41,540 | N/A | N/A |
| Other shareholders' equity | 861 | 0 | 0 |
| TOTAL | $-39,909 | $N/A | $N/A |
| Total Liabilities And Equity | $100,461 | $0 | $0 |